Effect of decreasing plasma free fatty acids by acipimox on hepatic glucose metabolism in normal rats

Metabolism: Clinical and Experimental

Volumn 45, Issue 11, 1996, Pages 1408-1414

  Lee, Ki Up ^a,b   Park, Joong Y ^a   Kim, Chul H ^a   Hong, Sung K ^a   Suh, Kyo I ^a   Park, Kyung S ^a   Park, Suna W ^a  

^a Hallym University   (South Korea)

^b Asan Medical Center   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ACIPIMOX;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOREGULATION; CONTROLLED STUDY; FATTY ACID BLOOD LEVEL; GLUCONEOGENESIS; GLUCOSE METABOLISM; GLUCOSE UTILIZATION; GLYCOGENOLYSIS; GLYCOLYSIS; HORMONAL REGULATION; HYPERINSULINEMIA; INSULIN RESISTANCE; LIVER METABOLISM; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RAT;

EID: 0029803469     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(96)90123-7     Document Type: Article

References (46)

1. Randle PJ, Garland PB, Hales CN, et al: The glucose fatty acid cycle: Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1:785-789, 1963
2. Foley JE: Rationale and application of fatty acid oxidation inhibitors in treatment of diabetes mellitus. Diabetes Care 15:773-784, 1992
3. Kim JK, Wi JK, Youn JH: Plasma free fatty acids decrease insulin-stimulated skeletal muscle glucose uptake by, suppressing glycolysis in conscious rats. Diabetes 45:446-453, 1996
4. Thiebaud DD, DeFronzo DA, Jacot E, et al: Effect of long-chain triglyceride infusion on glucose metabolism in man. Metabolism 31:1128-1136, 1982
5. Felber JP, Haesler E, Jequier E: Metabolic origin of insulin resistance in obesity with and without type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 36:1221-1229, 1993
6. Kelley DE, Mokan M, Simoneau JA, et al: Interaction between glucose and free fatty acid metabolism in human skeletal muscle. J Clin Invest 92:91-98, 1993
7. Friedman B, Goodman EH Jr, Weinhouse S: Effects of insulin and fatty acids on gluconeogenesis in the rat. J Biol Chem 242:3620-3627, 1967
8. Ferrannini E, Barrett EJ, Bevilacqua S, et al: Effect of fatty acids on glucose production and utilization in man. J Clin Invest 72:1737-1747, 1983
9. Lee KU, Lee HK, Koh CS, et al: Artificial induction of intravascular lipolysis by lipid-heparin infusion leads to insulin resistance in man. Diabetologia 31:285-290, 1988
10. Saloranta C, Franssila-Kallunki A, Ekstrand A, et al: Modulation of hepatic glucose production by non-esterified fatty acids in type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia 34:409-415, 1991
11. Walker M, Agius L, Orskov H, et al: Peripheral and hepatic insulin sensitivity in non-insulin-dependent diabetes mellitus: Effect of nonesterified fatty acids. Metabolism 42:601-608, 1993
12. Johnston P, Hollenbeck C, Sheu W, et al: Acute changes in plasma non-esterified fatty acid concentration do not change hepatic glucose production in people with type 2 diabetes. Diabet Med 7:871-875, 1990
13. Puhakainen I, Yki-Jarvinen H: Inhibition of lipolysis decreases lipid oxidation and gluconeogenesis from lactate but not fasting hyperglycemia or total hepatic glucose production in NIDDM. Diabetes 42:1694-1699, 1993
14. Clore JN, Glickman PS, Helm ST, et al: Evidence for dual control mechanism regulating hepatic glucose output in nondiabetic men. Diabetes 40:1033-1040, 1991
15. Clore JN, Glickman PS, Nestler JE, et al: In vivo evidence for hepatic autoregulation during FFA-stimulated gluconeogenesis in normal humans. Am J Physiol 261:E425-E429, 1991
16. Al-Shurbaji A, Berglund L, Bjorkhem I: The effect of acipimox on triacylglycerol metabolism in rat. Scand J Clin Lab Invest 50:203-208, 1990
17. Buchanan TA, Youn JH, Campese VM, et al: Enhanced glucose tolerance in spontaneously hypertensive rats: Pancreatic B-cell hyperfunction with normal insulin sensitivity. Diabetes 41:872-878, 1992
18. Buchanan TA, Sipos GF, Madrilejo N, et al: Hypertension without peripheral insulin resistance in spontaneously hypertensive rats. Am J Physiol 262:E14-E19, 1992
19. Liu Z, Gardner LB, Barrett EJ: Insulin and glucose suppress hepatic glycogenolysis by distinct enzymatic mechanisms. Metabolism 42:1546-1551, 1993
20. Shimizu S, Tani Y, Yamada H, et al: Enzymatic determination of serum free fatty acids: A calorimetric method. Anal Biochem 107:193-198, 1980
21. Kari I, Pagliaris A, Kipnis D: A microfluorometric enzymatic assay for determination of alanine and pyruvate in plasma and tissues. J Lab Clin Med 80:434-441, 1972
22. Chan TM, Exton JH: A rapid method for the determination of glycogen content and radioactivity in small quantities of tissue or isolated hepatocytes. Anal Biochem 71:96-105, 1976
23. Michal G: D-Glucose 6-phosphate and D-fructose 6-phosphate, in Bergmeyer NU (ed): Methods of Enzymatic Analysis, vol 6. Weinheim, Germany, Verlagsgesellschaft, 1985, pp 191-198
24. Kraegen EW, James DE, Jenkins AB, et al: Dose-response curves for in vivo insulin sensitivity in individual tissues in rats. Am J Physiol 248:E353-E362, 1985
25. Kreisberg RA, Siegal AM, Owen WC: Alanine and gluconeo-genesis in man: Effect of ethanol. J Clin Endocrinol 34:876-883, 1972
26. 14C glucose. Recent Prog Horm Res 19:445-448, 1963
27. Chiasson JL, Liljenquist J, Lacy WW, et al: Gluconeogenesis: Methodological approaches in vivo. Fed Proc 36:229-235, 1977
28. Hendrick G, Wasserman DH, Frizzell RT, et al: Importance of basal glucagon in maintaining hepatic glucose production during a prolonged fast in conscious dogs. Am J Physiol 263:E541-E549, 1992
29. Penicaud L, Ferre P, Kande J, et al: Effect of anesthesia on glucose production and utilization in rats. Am J Physiol 252:E365-E369, 1987
30. Clarke P, Jenkins AB, Kraegen EW: Pentobarbital reduces basal liver glucose output and its insulin suppression in rats. Am J Physiol 258:E701-E707, 1990
31. Smith D, Rossetti L, Ferrannini E, et al: In vivo glucose metabolism in the awake rat: Tracer and insulin clamp studies. Metabolism 36:1167-1174, 1987
32. Koopmans SJ, De Boer SF, Sips HCM, et al: Whole body and hepatic insulin action in normal, starved, and diabetic rats. Am J Physiol 260:E825-E832, 1991
33. Vaag A, Skott P, Damsbo P, et al: Effect of the antilipolytic nicotinic acid analogue acipimox on whole-body and skeletal muscle glucose metabolism in patients with non-insulin-dependent diabetes mellitus. J Clin Invest 88:1282-1290, 1991
34. Fulcher GR, Walker M, Farrer M, et al: Acipimox increases glucose disposal in normal man independent of changes in plasma nonesterifled fatty acid concentration and whole-body lipid oxidation rate. Metabolism 42:308-314, 1993
35. Blumenthal SA: Stimulation of gluconeogenesis by palmitic acid in rat hepatocytes: Evidence that this effect can be dissociated from the provision of reducing equivalents. Metabolism 32:971-976, 1983
36. Puhakainen I, Koivisto V, Yki-Jarvinen H: No reduction in total hepatic glucose output by inhibition of gluconeogenesis with ethanol in NIDDM patients. Diabetes 40:1319-1327, 1991
37. Jenssen T, Nurjhan N, Consoli A, et al: Failure of substrate-induced gluconeogenesis to increase overall glucose appearance in normal humans: Demonstration of hepatic autoregulation without a change in plasma glucose concentration. J Clin Invest 86:489-497, 1990
38. Kubota M, Vikamaki A, Yki-Jarvinen H: Ethanol stimulates glycogenolysis in livers from fed rats. Proc Soc Exp Biol Med 201:114-118, 1992
39. Hems D, Whitton P: Control of hepatic glycogenolysis. Physiol Rev 60:1-50, 1980
40. Warnotte C, Gilon P, Nenquin M, et al: Mechanisms of the stimulation of insulin release by saturated fatty acids: A study of palmitate effects in mouse B-cells. Diabetes 43:703-711, 1994
41. Farrer M, Fulcher GR, Johnson AJ, et al: Effect of acute inhibition of lipolysis on operation of the glucose-fatty acid cycle in hepatic cirrhosis. Metabolism 41:465-470, 1992
42. Landau C, Chen YDI, Skowronski R, et al: Effect of nicotinic acid on plasma glucose concentration in normal individuals. Horm Metab Res 24:424-428, 1992
43. Fanelli C, Calderone S, Epifano L, et al: Demonstration of a critical role for free fatty acids in mediating counterregulatory stimulation of gluconeogenesis and suppression of glucose utilization in humans. J Clin Invest 92:1617-1622, 1993
44. Steiner KE, Williams PE, Lacy WW, et al: Effects of insulin on glucagon-stimulated glucose production in the conscious dog. Metabolism 39:1325-1333, 1990
45. Krebs HA, Hems R, Weideman MJ, et al: The fate of isotopic carbon in kidney cortex synthesizing glucose from lactate. Biochem J 101:242-249, 1966
46. Consoli A, Kennedy F, Miles J, et al: Determination of Krebs cycle metabolic carbon exchange in vivo and its use to estimate the individual contributions of gluconeogenesis and glycogenolysis to overall glucose output in man. J Clin Invest 80:1303-1310, 1987